Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Efficacy of paxil in the treatment of depressions in elderly males

https://doi.org/10.14412/2074-2711-2012-386

Full Text:

Abstract

Objective: to study the efficacy of paxil in the treatment of depression of varying severity in elderly male. Patients and methods. Thirty-five males aged 50—78 years with depressive symptoms of varying severity in the framework of a depressive episode [n = 14 (40%)], recurrent depressive disorder [n = 12 (34.3%)], and bipolar affective disorder [n = 9 (25.7%)] were examined. The efficacy of paxil 20—40 mg/day was clinically evaluated using psychometric scales (CGI, HDRS, and UKU) on days 7, 14, 28, and 42. Results. Paxil was found to be highly effective in treating depressions in elderly males. The mean HDRS scores decreased from 24.7±0.3 to 4.9±1.1. By day 42, the reduction in depressive symptoms was 80.2%. 74.3% of the patients achieved recovery and a borderline state according to the CGI-S scale. There was cessation of asthenic symptoms and adynamia at week 1 of therapy, hypothymia at week 2, and anxiety caused by the consecutive manifestations of stimulating, antidepressant, and anxiolytic effects.

About the Authors

N A Tyuvina

Department of Psychiatry and Medical Psychology, I.M. Sechenov First Moscow State Medical University


S V Prokhorova

Department of Psychiatry and Medical Psychology, I.M. Sechenov First Moscow State Medical University


T N Maksimova

Department of Psychiatry and Medical Psychology, I.M. Sechenov First Moscow State Medical University


References

1. <div><p>Kay D.W., Beamish P., Roth M. Old age mental disorders in Newcastle Upon Tyne, Part 1: a study of prevalence. British J Psychiatr 1964;110:146—58.</p><p>Copeland J.R.M., Beekman A.T.F., Dewey M.E. at al. Depression in Europe: geographical distribution among older people. British J Psychiatr 1999;174:312—21.</p><p>Mayou R., Hawton K. Psychiatric morbidity in the general hospital. British J Psychiatr 1986;149:172—90.</p><p>Katona C.L.E. Depression in Old Age. Chichester: John Wiley, 1994.</p><p>Robert R.E., Kaplan G.A., Shema S.J. et al. Does growing old increase the risk for depression? Am J Psychiatr 1997;154:1384—90.</p><p>Kennedy G.J., Kelman H.R., Thomas C. The emergence of depressive symptoms in late life: the importance of declining health and increasing disability. J Com Health 1990;15:93—104.</p><p>Blazer D.G. Depression in late life: review and commentary. J Gerontol 2003;58A:249—65.</p><p>Alexopoulos G.S. Depression in the elderly. Lancet 2005;365(9475):1961—70.</p><p>Baldwin R.C. Depression in later life. Oxford: University press, 2010; 118 p.</p><p>Тювина Н.А., Балабанова В.В., Гонч Е.М. Опыт применения сульпирида при эндогенных депрессивно-ипохондрических расстройствах непсихотического уровня. Неврол нейропсихиатр психосом 2011;4:69—72.</p><p>Evans M.E., Copeland J.R.M., Dewey M.E. Depression in the elderly in the community: effect of physical illness and selected social factors. Int J Geriatr Psychiatry 1991;6:787—95.</p><p>Katona C.L.E., Manela M., Livingston G. Comorbidity with depression in older peopl: the Islington Study. Aging Ment Health 1997;1:57—61.</p><p>Livingston G., Hawkins A., Graham N. et al. The Gospel Oak Study: prevalence rates of dementia, depression and activity limitation among elderly residents in inner London. Psyhol Med 1990;20:137—46.</p><p>Forsell Y., Jorm A.F., Winblad B. Association of age, sex, cognitive dysfunction and disability with major depressive symptoms in an elderly depressive sample. Am J Psychiatry 1994;151:1600—4.</p><p>Fenton F.R., Cole M.G., Engelsman F. et al. Depression in older medical inpatients. Int J Geriatr Psychiatry 1994;9:279—84.</p><p>Beekman A.T.F., Kriegsman D.M.W., Deeg D.J.H. The association of physical health and depressive symptoms in the older population: age and sex differences. Soc Psychiatry Psychiatr Epidemiol 1995;30:32—8.</p><p>Авербух Е.С. Расстройства психической деятельности в позднем возрасте. М.: Медицина, 1968; 269 с.</p><p>Thomas D.R., Nelson D.R., Johnson A.M. Biochemical effects of antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor. Psychopharmacol 1987;93:193—200.</p><p>Tulloch I.F., Johnson A.M. The pharmacologic profile of paroxetine, a new selective serotoniknreuptake inhibitor. J Clin Psychiatr 1992;53(Suppl. 2):7—12.</p><p>Bignmini A., Rapisarda V. A double-blind multicentre study of paroxetine and amitriptyline in depressed outpatients. Int Clin Psychopharmacol 1992;6(Suppl. 4):37—41.</p><p>Мосолов С.Н., Смулевич А.Б., Григорьевских В.С. и др. Клиническая эффективность и переносимость препарата паксил (пароксетин) при умеренной и тяжелой депрессии. В сб.: Новые достижения в терапии психических заболеваний. Под ред. С.Н. Мосолова. М., 2002; 266—77.</p><p>Anderson I.M., Tomenson B.M. Theefficiacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis against trycyclic antidepressants. J Psychopharmacol 1994;8:238—49.</p><p>Dunbar G.C., Cohn J.B., Fabre L.F. et al. A comparison of paroxetine, imipramine, and placebo in depressed out-patients. Br J Psychiatr 1991;159:394—8.</p><p>Linc C., Dunbar G.C. An overview of studies comparing the efficacy, safety and tolerability of paroxetine and clomipramine. Nord J Psychiat 1992;46(Suppl. 27):17—22.</p><p>Mongomery S.A., Kasper S. Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressans: a metha-analysis. Int Clin Psychopharmacol 1995: (Suppl. 4):33—40.</p><p>Stoth P., Blagden M.D., Aitken C.A. Depression and associated anxiety in primary care: a double-blind comparison of pа roxetine and amitriptyline. Eur Neuropsychopharmacol 1993;3:324—5.</p><p>Trivedi M.N., Pigotti T.A., Perera P. at al. Effectivenes of low doses of paroxetine controlled release in the treatment of major depressive disorder J Clin Psychiatr 2004;65(Suppl. 10):1356—64.</p><p>Kiev A. A double-blind placebo-controlled study of paroxetine in depressed outpatients. J Clint Psychiatr 1992;53(Suppl. 2):27—9.</p><p>Rickels K., Amsterdam J., Clary C. et al. The officacy and safety of paroxetine compared with placebo in outpatients with major depression. J Clin Psychiatr 1992;53(Suppl. 2):31 — 1.</p><p>Roose S.P., Schatatzberg A.F. The efficacy of antidepressants in the treatment of late-life-depression. J Clin Psychopharmacol 2005;25:S1—S7.</p></div><br />


For citation:


Tyuvina N.A., Prokhorova S.V., Maksimova T.N. Efficacy of paxil in the treatment of depressions in elderly males. Neurology, Neuropsychiatry, Psychosomatics. 2012;4(2):63-68. (In Russ.) https://doi.org/10.14412/2074-2711-2012-386

Views: 425


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)